Skip to main content
Top
Published in: BMC Infectious Diseases 1/2018

Open Access 01-12-2018 | Research article

Epidemiological characterization of respiratory tract infections caused by Mycoplasma pneumoniae during epidemic and post-epidemic periods in North China, from 2011 to 2016

Authors: Jiuxin Qu, Chunxia Yang, Fang Bao, Shuyan Chen, Li Gu, Bin Cao

Published in: BMC Infectious Diseases | Issue 1/2018

Login to get access

Abstract

Background

Mycoplasma pneumoniae (M. pneumoniae) is a commonly causative pathogen for respiratory tract infections (RTIs) in humans. The epidemiological features of M. pneumoniae infections during post-epidemic, including age distribution and the seasonality of the patients, are not well investigated.

Methods

We retrospectively analyzed the clinical data of 7835 consecutive RTIs patients (3852 adults and 3983 children) who visited a teaching hospital, and defined an epidemic (2011–2013) and a post-epidemic period (2014–2016). M. pneumoniae was detected by fluorescence-quantatitive PCR in respiratory samples. Informed consent was obtained by all adults and the legal representatives of patients aged < 18 years, and the study was approved by Institutional Review Board of Beijing Chao-Yang Hospital (project approval number 10-KE-49).

Results

The median (IQR) age was 16 (53) years (range < 0–105 years). The M. pneumoniae positive rate was 14.4% (21.2%, epidemic; 6.7%, post-epidemic), with seasonal peaks from late summer to autumn during epidemic, and from fall to winter during post-epidemic period, which was highest in children aged 7–17 years. In epidemic, no statistical difference was found in the positive rates between children and adults among most months (except February, July and August), neither for the positive rates among age groups (P = 0.801). However, in post-epidemic period, significant differences were observed in the positive rates between children and adults in nearly every month (P< 0.05 or P< 0.001, except May), as well as in the positive rates among age groups (P< 0.001). Most of the older patient admissions and all of ICU admissions occurred during the epidemic.

Conclusions

Different patterns of age distribution and seasonality of M. pneumoniae RTIs between epidemic and post-epidemic periods were reported. Our results suggest that M. pneumoniae should be considered as a possible pathogen in pneumonia patients admitted to the ICU in the setting of an epidemic.
Appendix
Available only for authorised users
Literature
1.
go back to reference Atkinson TP, Balish MF, Waites KB. Epidemiology, clinical manifestations, pathogenesis and laboratory detection of mycoplasma pneumoniae infections. FEMS Microbiol Rev. 2008;32(6):956–73.CrossRefPubMed Atkinson TP, Balish MF, Waites KB. Epidemiology, clinical manifestations, pathogenesis and laboratory detection of mycoplasma pneumoniae infections. FEMS Microbiol Rev. 2008;32(6):956–73.CrossRefPubMed
2.
go back to reference Cao B, Zhao CJ, Yin YD, Zhao F, Song SF, Bai L, Zhang JZ, Liu YM, Zhang YY, Wang H, et al. High prevalence of macrolide resistance in mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China. Clin Infect Dis. 2010;51(2):189–94.CrossRefPubMed Cao B, Zhao CJ, Yin YD, Zhao F, Song SF, Bai L, Zhang JZ, Liu YM, Zhang YY, Wang H, et al. High prevalence of macrolide resistance in mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China. Clin Infect Dis. 2010;51(2):189–94.CrossRefPubMed
3.
go back to reference Waites KB, Bébéar CM, Robertson JA, Talkington DF, Kenny GE. Cumitech 34, Laboratory diagnosis of mycoplasmal infections. Coordinating ed, Nolte FS. Washington, DC: ASM Press; 2001. Waites KB, Bébéar CM, Robertson JA, Talkington DF, Kenny GE. Cumitech 34, Laboratory diagnosis of mycoplasmal infections. Coordinating ed, Nolte FS. Washington, DC: ASM Press; 2001.
4.
go back to reference Chalker V, Stocki T, Litt D, Bermingham A, Watson J, Fleming D, Harrison T. Increased detection of mycoplasma pneumoniae infection in children in England and Wales, October 2011 to January 2012. Euro Surveill. 2012;17(6). Chalker V, Stocki T, Litt D, Bermingham A, Watson J, Fleming D, Harrison T. Increased detection of mycoplasma pneumoniae infection in children in England and Wales, October 2011 to January 2012. Euro Surveill. 2012;17(6).
5.
go back to reference Eibach D, Casalegno JS, Escuret V, Billaud G, Mekki Y, Frobert E, Bouscambert-Duchamp M, Lina B, Morfin F. Increased detection of mycoplasma pneumoniae infection in children, Lyon, France, 2010 to 2011. Euro Surveill. 2012;17(8). Eibach D, Casalegno JS, Escuret V, Billaud G, Mekki Y, Frobert E, Bouscambert-Duchamp M, Lina B, Morfin F. Increased detection of mycoplasma pneumoniae infection in children, Lyon, France, 2010 to 2011. Euro Surveill. 2012;17(8).
6.
go back to reference Pitcher D, Chalker VJ, Sheppard C, George RC, Harrison TG. Real-time detection of mycoplasma pneumoniae in respiratory samples with an internal processing control. J Med Microbiol. 2006;55(Pt 2):149–55.CrossRefPubMed Pitcher D, Chalker VJ, Sheppard C, George RC, Harrison TG. Real-time detection of mycoplasma pneumoniae in respiratory samples with an internal processing control. J Med Microbiol. 2006;55(Pt 2):149–55.CrossRefPubMed
7.
go back to reference Qu J, Gu L, Wu J, Dong J, Pu Z, Gao Y, Hu M, Zhang Y, Gao F, Cao B, et al. Accuracy of IgM antibody testing, FQ-PCR and culture in laboratory diagnosis of acute infection by mycoplasma pneumoniae in adults and adolescents with community-acquired pneumonia. BMC Infect Dis. 2013;13:172.CrossRefPubMedPubMedCentral Qu J, Gu L, Wu J, Dong J, Pu Z, Gao Y, Hu M, Zhang Y, Gao F, Cao B, et al. Accuracy of IgM antibody testing, FQ-PCR and culture in laboratory diagnosis of acute infection by mycoplasma pneumoniae in adults and adolescents with community-acquired pneumonia. BMC Infect Dis. 2013;13:172.CrossRefPubMedPubMedCentral
8.
go back to reference Lind K, Benzon MW, Jensen JS, Clyde WA Jr. A seroepidemiological study of mycoplasma pneumoniae infections in Denmark over the 50-year period 1946-1995. Eur J Epidemiol. 1997;13(5):581–6.CrossRefPubMed Lind K, Benzon MW, Jensen JS, Clyde WA Jr. A seroepidemiological study of mycoplasma pneumoniae infections in Denmark over the 50-year period 1946-1995. Eur J Epidemiol. 1997;13(5):581–6.CrossRefPubMed
9.
go back to reference Lenglet A, Herrador Z, Magiorakos AP, Leitmeyer K, Coulombier D. European working group on mycoplasma pneumoniae s: surveillance status and recent data for mycoplasma pneumoniae infections in the European Union and European economic area, January 2012. Euro Surveill. 2012;17(5). Lenglet A, Herrador Z, Magiorakos AP, Leitmeyer K, Coulombier D. European working group on mycoplasma pneumoniae s: surveillance status and recent data for mycoplasma pneumoniae infections in the European Union and European economic area, January 2012. Euro Surveill. 2012;17(5).
10.
go back to reference Nir-Paz R, Abutbul A, Moses AE, Block C, Hidalgo-Grass C. Ongoing epidemic of mycoplasma pneumoniae infection in Jerusalem, Israel, 2010 to 2012. Euro Surveill. 2012;17(8). Nir-Paz R, Abutbul A, Moses AE, Block C, Hidalgo-Grass C. Ongoing epidemic of mycoplasma pneumoniae infection in Jerusalem, Israel, 2010 to 2012. Euro Surveill. 2012;17(8).
11.
go back to reference Chalker V, Stocki T, Mentasti M, Fleming D, Harrison T. Increased incidence of mycoplasma pneumoniae infection in England and Wales in 2010: multiocus variable number tandem repeat analysis typing and macrolide susceptibility. Euro Surveill. 2011;16(19). Chalker V, Stocki T, Mentasti M, Fleming D, Harrison T. Increased incidence of mycoplasma pneumoniae infection in England and Wales in 2010: multiocus variable number tandem repeat analysis typing and macrolide susceptibility. Euro Surveill. 2011;16(19).
12.
go back to reference Waller JL, Diaz MH, Petrone BL, Benitez AJ, Wolff BJ, Edison L, Tobin-D'Angelo M, Moore A, Martyn A, Dishman H, et al. Detection and characterization of mycoplasma pneumoniae during an outbreak of respiratory illness at a university. J Clin Microbiol. 2014;52(3):849–53.CrossRefPubMedPubMedCentral Waller JL, Diaz MH, Petrone BL, Benitez AJ, Wolff BJ, Edison L, Tobin-D'Angelo M, Moore A, Martyn A, Dishman H, et al. Detection and characterization of mycoplasma pneumoniae during an outbreak of respiratory illness at a university. J Clin Microbiol. 2014;52(3):849–53.CrossRefPubMedPubMedCentral
13.
go back to reference Diaz MH, Benitez AJ, Winchell JM. Investigations of mycoplasma pneumoniae infections in the United States: trends in molecular typing and macrolide resistance from 2006 to 2013. J Clin Microbiol. 2015;53(1):124–30.CrossRefPubMed Diaz MH, Benitez AJ, Winchell JM. Investigations of mycoplasma pneumoniae infections in the United States: trends in molecular typing and macrolide resistance from 2006 to 2013. J Clin Microbiol. 2015;53(1):124–30.CrossRefPubMed
14.
go back to reference Chironna M, Loconsole D, De Robertis AL, Morea A, Scalini E, Quarto M, Tafuri S, Germinario C, Manzionna M. Clonal spread of a unique strain of macrolide-resistant mycoplasma pneumoniae within a single family in Italy. Medicine. 2016;95(11):e3160.CrossRefPubMedPubMedCentral Chironna M, Loconsole D, De Robertis AL, Morea A, Scalini E, Quarto M, Tafuri S, Germinario C, Manzionna M. Clonal spread of a unique strain of macrolide-resistant mycoplasma pneumoniae within a single family in Italy. Medicine. 2016;95(11):e3160.CrossRefPubMedPubMedCentral
15.
go back to reference Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File TM Jr, Rello J, et al. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007;175(10):1086–93.CrossRefPubMed Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File TM Jr, Rello J, et al. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007;175(10):1086–93.CrossRefPubMed
16.
go back to reference Feikin DR, Moroney JF, Talkington DF, Thacker WL, Code JE, Schwartz LA, Erdman DD, Butler JC, Cetron MS. An outbreak of acute respiratory disease caused by mycoplasma pneumoniae and adenovirus at a federal service training academy: new implications from an old scenario. Clin Infect Dis. 1999;29(6):1545–50.CrossRefPubMed Feikin DR, Moroney JF, Talkington DF, Thacker WL, Code JE, Schwartz LA, Erdman DD, Butler JC, Cetron MS. An outbreak of acute respiratory disease caused by mycoplasma pneumoniae and adenovirus at a federal service training academy: new implications from an old scenario. Clin Infect Dis. 1999;29(6):1545–50.CrossRefPubMed
17.
go back to reference Kim EK, Youn YS, Rhim JW, Shin MS, Kang JH, Lee KY. Epidemiological comparison of three mycoplasma pneumoniae pneumonia epidemics in a single hospital over 10 years. Korean J Pediatr. 2015;58(5):172–7.CrossRefPubMedPubMedCentral Kim EK, Youn YS, Rhim JW, Shin MS, Kang JH, Lee KY. Epidemiological comparison of three mycoplasma pneumoniae pneumonia epidemics in a single hospital over 10 years. Korean J Pediatr. 2015;58(5):172–7.CrossRefPubMedPubMedCentral
18.
go back to reference Kogoj R, Mrvic T, Praprotnik M, Kese D. Prevalence, genotyping and macrolide resistance of mycoplasma pneumoniae among isolates of patients with respiratory tract infections, Central Slovenia, 2006 to 2014. Euro Surveill. 2015;20(37). Kogoj R, Mrvic T, Praprotnik M, Kese D. Prevalence, genotyping and macrolide resistance of mycoplasma pneumoniae among isolates of patients with respiratory tract infections, Central Slovenia, 2006 to 2014. Euro Surveill. 2015;20(37).
19.
go back to reference Diaz MH, Benitez AJ, Cross KE, Hicks LA, Kutty P, Bramley AM, Chappell JD, Hymas W, Patel A, Qi C, et al. Molecular detection and characterization of mycoplasma pneumoniae among patients hospitalized with community-acquired pneumonia in the United States. Open Forum Infect Dis. 2015;2(3):ofv106.CrossRefPubMedPubMedCentral Diaz MH, Benitez AJ, Cross KE, Hicks LA, Kutty P, Bramley AM, Chappell JD, Hymas W, Patel A, Qi C, et al. Molecular detection and characterization of mycoplasma pneumoniae among patients hospitalized with community-acquired pneumonia in the United States. Open Forum Infect Dis. 2015;2(3):ofv106.CrossRefPubMedPubMedCentral
20.
go back to reference Sun H, Xue G, Yan C, Li S, Zhao H, Feng Y, Wang L. Changes in molecular characteristics of mycoplasma pneumoniae in clinical specimens from children in Beijing between 2003 and 2015. PLoS One. 2017;12(1):e0170253.CrossRefPubMedPubMedCentral Sun H, Xue G, Yan C, Li S, Zhao H, Feng Y, Wang L. Changes in molecular characteristics of mycoplasma pneumoniae in clinical specimens from children in Beijing between 2003 and 2015. PLoS One. 2017;12(1):e0170253.CrossRefPubMedPubMedCentral
21.
go back to reference Ma YJ, Wang SM, Cho YH, Shen CF, Liu CC, Chi H, Huang YC, Huang LM, Huang YC, Lin HC, et al. Clinical and epidemiological characteristics in children with community-acquired mycoplasma pneumonia in Taiwan: a nationwide surveillance. J Microbiol Immunol Infect = Wei mian yu gan ran za zhi. 2015;48(6):632–8.CrossRefPubMed Ma YJ, Wang SM, Cho YH, Shen CF, Liu CC, Chi H, Huang YC, Huang LM, Huang YC, Lin HC, et al. Clinical and epidemiological characteristics in children with community-acquired mycoplasma pneumonia in Taiwan: a nationwide surveillance. J Microbiol Immunol Infect = Wei mian yu gan ran za zhi. 2015;48(6):632–8.CrossRefPubMed
22.
go back to reference Kawai Y, Miyashita N, Kubo M, Akaike H, Kato A, Nishizawa Y, Saito A, Kondo E, Teranishi H, Wakabayashi T, et al. Nationwide surveillance of macrolide-resistant mycoplasma pneumoniae infection in pediatric patients. Antimicrob Agents Chemother. 2013;57(8):4046–9.CrossRefPubMedPubMedCentral Kawai Y, Miyashita N, Kubo M, Akaike H, Kato A, Nishizawa Y, Saito A, Kondo E, Teranishi H, Wakabayashi T, et al. Nationwide surveillance of macrolide-resistant mycoplasma pneumoniae infection in pediatric patients. Antimicrob Agents Chemother. 2013;57(8):4046–9.CrossRefPubMedPubMedCentral
23.
24.
go back to reference Onozuka D, Hashizume M, Hagihara A. Impact of weather factors on mycoplasma pneumoniae pneumonia. Thorax. 2009;64(6):507–11.CrossRefPubMed Onozuka D, Hashizume M, Hagihara A. Impact of weather factors on mycoplasma pneumoniae pneumonia. Thorax. 2009;64(6):507–11.CrossRefPubMed
25.
go back to reference Brown RJ, Nguipdop-Djomo P, Zhao H, Stanford E, Spiller OB, Chalker VJ. Mycoplasma pneumoniae epidemiology in England and Wales: a National Perspective. Front Microbiol. 2016;7:157.CrossRefPubMedPubMedCentral Brown RJ, Nguipdop-Djomo P, Zhao H, Stanford E, Spiller OB, Chalker VJ. Mycoplasma pneumoniae epidemiology in England and Wales: a National Perspective. Front Microbiol. 2016;7:157.CrossRefPubMedPubMedCentral
26.
go back to reference Pereyre S, Charron A, Hidalgo-Grass C, Touati A, Moses AE, Nir-Paz R, Bebear C. The spread of mycoplasma pneumoniae is polyclonal in both an endemic setting in France and in an epidemic setting in Israel. PLoS One. 2012;7(6):e38585.CrossRefPubMedPubMedCentral Pereyre S, Charron A, Hidalgo-Grass C, Touati A, Moses AE, Nir-Paz R, Bebear C. The spread of mycoplasma pneumoniae is polyclonal in both an endemic setting in France and in an epidemic setting in Israel. PLoS One. 2012;7(6):e38585.CrossRefPubMedPubMedCentral
27.
go back to reference Pereyre S, Touati A, Petitjean-Lecherbonnier J, Charron A, Vabret A, Bebear C. The increased incidence of mycoplasma pneumoniae in France in 2011 was polyclonal, mainly involving M. Pneumoniae type 1 strains. Clin Microbiol Infect. 2013;19(4):E212–7.CrossRefPubMed Pereyre S, Touati A, Petitjean-Lecherbonnier J, Charron A, Vabret A, Bebear C. The increased incidence of mycoplasma pneumoniae in France in 2011 was polyclonal, mainly involving M. Pneumoniae type 1 strains. Clin Microbiol Infect. 2013;19(4):E212–7.CrossRefPubMed
28.
go back to reference Barile MF, Grabowski MW, Kapatais-Zoumbois K, Brown B, Hu PC, Chandler DK. Protection of immunized and previously infected chimpanzees challenged with mycoplasma pneumoniae. Vaccine. 1994;12(8):707–14.CrossRefPubMed Barile MF, Grabowski MW, Kapatais-Zoumbois K, Brown B, Hu PC, Chandler DK. Protection of immunized and previously infected chimpanzees challenged with mycoplasma pneumoniae. Vaccine. 1994;12(8):707–14.CrossRefPubMed
29.
go back to reference Omori R, Nakata Y, Tessmer HL, Suzuki S, Shibayama K. The determinant of periodicity in mycoplasma pneumoniae incidence: an insight from mathematical modelling. Sci Rep. 2015;5:14473.CrossRefPubMedPubMedCentral Omori R, Nakata Y, Tessmer HL, Suzuki S, Shibayama K. The determinant of periodicity in mycoplasma pneumoniae incidence: an insight from mathematical modelling. Sci Rep. 2015;5:14473.CrossRefPubMedPubMedCentral
31.
go back to reference Ou ZY, Zhou R, Wang FH, Lu JP, Xia JQ, Xia HM, Zhang JT, Gong ST, Deng L, Wu ZH, et al. Retrospective analysis of mycoplasma pneumoniae infection in pediatric fatal pneumonia in Guangzhou, South China. Clin Pediatr. 2008;47(8):791–6.CrossRef Ou ZY, Zhou R, Wang FH, Lu JP, Xia JQ, Xia HM, Zhang JT, Gong ST, Deng L, Wu ZH, et al. Retrospective analysis of mycoplasma pneumoniae infection in pediatric fatal pneumonia in Guangzhou, South China. Clin Pediatr. 2008;47(8):791–6.CrossRef
32.
go back to reference Khoury T, Sviri S, Rmeileh AA, Nubani A, Abutbul A, Hoss S, van Heerden PV, Bayya AE, Hidalgo-Grass C, Moses AE, et al. Increased rates of intensive care unit admission in patients with mycoplasma pneumoniae: a retrospective study. Clin Microbiol Infect. 2016;22(8):711–4.CrossRefPubMed Khoury T, Sviri S, Rmeileh AA, Nubani A, Abutbul A, Hoss S, van Heerden PV, Bayya AE, Hidalgo-Grass C, Moses AE, et al. Increased rates of intensive care unit admission in patients with mycoplasma pneumoniae: a retrospective study. Clin Microbiol Infect. 2016;22(8):711–4.CrossRefPubMed
33.
go back to reference Petitjean J, Vabret A, Gouarin S, Freymuth F. Evaluation of four commercial immunoglobulin G (IgG)- and IgM-specific enzyme immunoassays for diagnosis of mycoplasma pneumoniae infections. J Clin Microbiol. 2002;40(1):165–71.CrossRefPubMedPubMedCentral Petitjean J, Vabret A, Gouarin S, Freymuth F. Evaluation of four commercial immunoglobulin G (IgG)- and IgM-specific enzyme immunoassays for diagnosis of mycoplasma pneumoniae infections. J Clin Microbiol. 2002;40(1):165–71.CrossRefPubMedPubMedCentral
34.
go back to reference Daxboeck F, Krause R, Wenisch C. Laboratory diagnosis of mycoplasma pneumoniae infection. Clin Microbiol Infect. 2003;9(4):263–73.CrossRefPubMed Daxboeck F, Krause R, Wenisch C. Laboratory diagnosis of mycoplasma pneumoniae infection. Clin Microbiol Infect. 2003;9(4):263–73.CrossRefPubMed
35.
go back to reference Martinez MA, Ruiz M, Zunino E, Luchsinger V, Avendano LF. Detection of mycoplasma pneumoniae in adult community-acquired pneumonia by PCR and serology. J Med Microbiol. 2008;57(Pt 12):1491–5.CrossRefPubMed Martinez MA, Ruiz M, Zunino E, Luchsinger V, Avendano LF. Detection of mycoplasma pneumoniae in adult community-acquired pneumonia by PCR and serology. J Med Microbiol. 2008;57(Pt 12):1491–5.CrossRefPubMed
36.
go back to reference Chaudhry R, Sharma S, Javed S, Passi K, Dey AB, Malhotra P. Molecular detection of mycoplasma pneumoniae by quantitative real-time PCR in patients with community acquired pneumonia. Indian J Med Res. 2013;138:244–51.PubMedPubMedCentral Chaudhry R, Sharma S, Javed S, Passi K, Dey AB, Malhotra P. Molecular detection of mycoplasma pneumoniae by quantitative real-time PCR in patients with community acquired pneumonia. Indian J Med Res. 2013;138:244–51.PubMedPubMedCentral
37.
go back to reference Foy HM. Infections caused by mycoplasma pneumoniae and possible carrier state in different populations of patients. Clin Infect Dis. 1993;17(Suppl 1):S37–46.CrossRefPubMed Foy HM. Infections caused by mycoplasma pneumoniae and possible carrier state in different populations of patients. Clin Infect Dis. 1993;17(Suppl 1):S37–46.CrossRefPubMed
38.
go back to reference Jain S, Williams DJ, Arnold SR, Ampofo K, Bramley AM, Reed C, Stockmann C, Anderson EJ, Grijalva CG, Self WH, et al. Community-acquired pneumonia requiring hospitalization among U.S. children. The New England journal of medicine. 2015;372(9):835–45.CrossRefPubMedPubMedCentral Jain S, Williams DJ, Arnold SR, Ampofo K, Bramley AM, Reed C, Stockmann C, Anderson EJ, Grijalva CG, Self WH, et al. Community-acquired pneumonia requiring hospitalization among U.S. children. The New England journal of medicine. 2015;372(9):835–45.CrossRefPubMedPubMedCentral
39.
go back to reference Gnarpe J, Lundback A, Sundelof B, Gnarpe H. Prevalence of mycoplasma pneumoniae in subjectively healthy individuals. Scand J Infect Dis. 1992;24(2):161–4.CrossRefPubMed Gnarpe J, Lundback A, Sundelof B, Gnarpe H. Prevalence of mycoplasma pneumoniae in subjectively healthy individuals. Scand J Infect Dis. 1992;24(2):161–4.CrossRefPubMed
Metadata
Title
Epidemiological characterization of respiratory tract infections caused by Mycoplasma pneumoniae during epidemic and post-epidemic periods in North China, from 2011 to 2016
Authors
Jiuxin Qu
Chunxia Yang
Fang Bao
Shuyan Chen
Li Gu
Bin Cao
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2018
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-018-3250-2

Other articles of this Issue 1/2018

BMC Infectious Diseases 1/2018 Go to the issue